Featured Speaker Spotlight: Omar Ali
Featured Speaker Spotlight: Omar Ali
Former NICE Adviser & Head of Payers, Verpora
Topic: Can We Afford a Cure? Paying for Innovative New Medicines with Value-Based Contracting
The rapid pace of pharmaceutical innovation is transforming healthcare outcomes worldwide. Breakthrough therapies—particularly in oncology, rare diseases, and gene-based treatments—are redefining what is clinically possible. However, these advancements also raise a critical question for healthcare systems, policymakers, and payers alike: Can we afford a cure?
This pressing issue will be addressed by Omar Ali, Former Government Adviser to NICE (UK) and Head of Payers at Verpora, at the 18th International Healthcare, Hospital Management, Nursing & Patient Safety Conference, taking place April 6–8, 2026, in Dubai, UAE.
About the Speaker
Omar Ali is a globally respected expert in health technology assessment (HTA), payer strategy, and innovative pharmaceutical contracting. As a former adviser to NICE (National Institute for Health and Care Excellence), he has worked at the intersection of government policy, healthcare economics, and market access.
Omar holds a PhD focused on innovative contracting for new medicines, with particular emphasis on value-based and outcomes-based reimbursement models. His academic and professional insights are further enriched through his role as a visiting lecturer at leading institutions, including:
University of Lisbon
University of Portsmouth
University College London (UCL)
Barcelona Business School
He has also served as a keynote speaker for AMCP (USA), engaging payer and pharmaceutical audiences on sustainable access to innovation.
Currently, as Head of Payers at Verpora, Omar leads a team of current and former payer professionals, advising life sciences organizations on navigating complex reimbursement landscapes. He is also the host of “The Payer Exchange” podcast, available on Spotify and Apple Music, where global payer perspectives and real-world access challenges are explored.
About the Topic
Can We Afford a Cure? Paying for Innovative New Medicines with Value-Based Contracting
Omar Ali’s session will explore one of the most critical challenges facing modern healthcare systems: balancing innovation, affordability, and patient access.
Key discussion points include:
The financial impact of high-cost innovative therapies
Limitations of traditional pricing and reimbursement models
The role of value-based contracting in aligning payment with real-world outcomes
Risk-sharing agreements between payers and manufacturers
Policy implications for governments, insurers, and healthcare providers
Future directions for sustainable access to breakthrough medicines
This session is highly relevant for healthcare leaders, policymakers, payers, pharmaceutical executives, clinicians, and health economists seeking practical frameworks for funding innovation without compromising system sustainability.
About the Conference
The 18th International Healthcare, Hospital Management, Nursing & Patient Safety Conference is a premier global forum bringing together healthcare leaders, researchers, clinicians, academicians, policymakers, and industry innovators from around the world.
Conference Highlights:
Evidence-based discussions on healthcare policy, innovation, and patient safety
Opportunities for networking, collaboration, and knowledge exchange
📍 Location: Dubai, UAE
📅 Dates: April 6–8, 2026
Important Links
🔗 Conference Homepage:
https://nursing-healthcare.utilitarianconferences.com/
🔗 Register Now:
https://nursing-healthcare.utilitarianconferences.com/registration
🔗 Submit Abstract:
https://nursing-healthcare.utilitarianconferences.com/submit-abstract
🔗 Speaker Profile:
https://nursing-healthcare.utilitarianconferences.com/speaker/omar-ali
Keywords
Healthcare innovation, Value-based contracting, Innovative medicines, Healthcare economics, Payer strategy, Health technology assessment, NICE adviser, Pharmaceutical pricing, Market access, Outcomes-based reimbursement, Healthcare policy, Sustainable healthcare, Drug affordability, Healthcare financing, Patient access, Pharmaceutical innovation, Risk-sharing agreements, Global healthcare conference, Hospital management, Nursing leadership, Patient safety, Healthcare leadership, Life sciences, Health economics, Dubai healthcare conference, Medical innovation, Policy decision-making, Healthcare systems, Payer perspectives, HTA frameworks, Pharmaceutical reimbursement, Value-based healthcare, Government healthcare policy, Clinical outcomes, Healthcare sustainability, Medical policy, Global health, Healthcare transformation, Evidence-based medicine
#OmarAli #HealthcareLeadership #ValueBasedContracting #InnovativeMedicines #HealthcareEconomics #HTA #NICE #PharmaInnovation #MarketAccess #PayerStrategy #HealthcarePolicy #PatientAccess #SustainableHealthcare #DrugAffordability #LifeSciences #HealthcareConference #Dubai2026 #GlobalHealthcare #HospitalManagement #NursingLeadership #PatientSafety #MedicalInnovation #HealthEconomics #HealthcareTransformation #OutcomesBasedCare #PharmaceuticalPolicy #HealthcareFinance #EvidenceBasedHealthcare #HealthSystems #MedicalLeadership #HealthcareProfessionals #PayersPerspective #HealthcareSummit #MedicalConference #HealthcareFuture #InnovationInHealthcare #GlobalHealthConference #HealthcareExperts #PolicyAndPractice

Comments
Post a Comment